Skip to main content
GutCited

Description

Comparative data on outcomes from in vivo models of enteropathy using top bacterial and protozoal pathogens, highlighting differential determinants across pathogen types. Accessible small animal models enable assessment of clinically important infection outcomes.

Cite This Figure

![Figure 9: Comparative data on outcomes from in vivo models of enteropathy using top bacterial and protozoal pathogens, highlighting differential determinants across pathogen types. Accessible small animal models enable assessment of clinically important infection outcomes.]()

> Source: Richard L Guerrant et al. "Modeling Enteropathy or Diarrhea with the Top Bacterial and Protozoal Pathogens:." *ACS infectious diseases*, 2021. PMID: [33901398](https://pubmed.ncbi.nlm.nih.gov/33901398/)
<figure>
  <img src="" alt="Comparative data on outcomes from in vivo models of enteropathy using top bacterial and protozoal pathogens, highlighting differential determinants across pathogen types. Accessible small animal models enable assessment of clinically important infection outcomes." />
  <figcaption>Figure 9. Comparative data on outcomes from in vivo models of enteropathy using top bacterial and protozoal pathogens, highlighting differential determinants across pathogen types. Accessible small animal models enable assessment of clinically important infection outcomes.<br>  Source: Richard L Guerrant et al. "Modeling Enteropathy or Diarrhea with the Top Bacterial and Protozoal Pathogens:." <em>ACS infectious diseases</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33901398/">33901398</a></figcaption>
</figure>